About Belhaven Biopharma
Belhaven Biopharma is a private company based in Chapel Hill, North Carolina, incorporated in 2020 in Delaware. It has reported $32,289,627 raised in one offering on Form D since October 2025. Its chief executive is Scott Lyman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2025 | Oct 15, 2025 | $32,289,627fully sold | 222 | $145K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Belhaven Biopharma's Form D filed Oct 15, 2025.
WW
Wes Wheeler
Director
DN
David Neal
Chief Financial Officer and Secretary, director
DW
Derek Winstanly
Director
SL
Scott Lyman
President and Chief Executive Officer, director